Press Releases

The Company has been Granted European Union Trademark Number: 018138334 NEW YORK, NY, Feb. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as...

Read More

TradersEXPO New York to be Attended by Accredited Individual Investors, Institutional Investors, and Investment Banking Firms  NEW YORK, NY, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution,...

Read More

The Company has finalized the formulation blueprint for its proposed Pharmaceutical Grade Version of Tauri-Gum™ NEW YORK, NY, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing...

Read More